InventionMed SA
0.11
PLN
0.00
(0.00%)
ISIN
PLCDE0000010
Return %
Stock
S&P 500
1Y
-26.33
14.20
3Y
-48.36
81.12
5Y
-52.84
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Tomasz Aleksander Kierul
- Full Time Employees
- 8
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Bydgoszcz Poland
- IPO Date
- Mar 25, 2013
- Website
- inventionmed.pl
- Similar Companies
- Business
- InventionMed S.A. is a medical technology company that develops virtual reality (VR) and augmented reality (AR) simulation systems for healthcare education and clinical training, with a primary specialization in clinical and aesthetic dermatology. The company designs and commercializes proprietary hardware and software solutions utilizing double immersion technology, which integrates three-dimensional visual immersion with realistic haptic feedback and anatomical phantoms to replicate tactile sensations and tissue resistance. Its core product and service portfolio comprises the TutorDerm medical simulator platform; specialized procedural simulation software for diagnosing and treating skin conditions, lesions, capillary hemangiomas, and vascular defects; the virtual syringe training device for practicing precision therapeutic and aesthetic injections; physical simulation phantoms mimicking human skin layers; interactive curriculum modules for clinical skills development; and custom research and development engineering services for medical simulation systems. InventionMed S.A. serves medical universities, teaching hospitals, aesthetic medicine clinics, cosmetology institutes, and specialized healthcare training facilities across Poland and the wider European market. In recent operational developments, the company completed construction and obtained the occupancy permit for its specialized Research and Development Center (CBR), functioning as an advanced virtual hospital facility in Bydgoszcz to scale VR and AR simulation capabilities across additional clinical fields including neurology and cardiology. The company has also advanced pilot implementations and clinical evaluations with institutions such as the Medical University of Warsaw and Collegium Medicum in Bydgoszcz, while maintaining strategic technology partnerships with software developers including SoftBlue S.A. Founded in 2012, InventionMed S.A. is headquartered in Bydgoszcz, Poland, and is publicly traded on the NewConnect market of the Warsaw Stock Exchange under the ticker INM.